Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Chrysos Corp. Ltd. ( (AU:C79) ) just unveiled an update.
Chrysos Corporation reported record operational performance, with its PhotonAssay™ fleet processing more than one million samples in both March and April 2026, marking a new utilisation high that supports accelerated average assay charges and strengthens key revenue and profitability drivers. The company has signed 19 new PhotonAssay™ lease agreements year to date, deepening partnerships with major laboratories ALS and Bureau Veritas, expanding direct-to-mine deployments including with Allied Gold, lifting its deployed fleet to 44 units, and affirming that FY26 revenue and EBITDA are tracking at the upper end of guidance as it prepares for faster global roll-outs into FY27 and completes a $200 million refinancing.
The most recent analyst rating on (AU:C79) stock is a Buy with a A$9.40 price target. To see the full list of analyst forecasts on Chrysos Corp. Ltd. stock, see the AU:C79 Stock Forecast page.
More about Chrysos Corp. Ltd.
Chrysos Corporation Ltd. is an Adelaide-headquartered technology company serving the global mining industry. Its flagship PhotonAssay™ product provides faster, safer, more accurate and environmentally friendly analysis of gold, silver, copper and other elements, targeting both mining companies and commercial assay laboratories worldwide.
Average Trading Volume: 384,218
Technical Sentiment Signal: Buy
Current Market Cap: A$856.2M
Find detailed analytics on C79 stock on TipRanks’ Stock Analysis page.